Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redesign of Implantable Cardiac Device Workflow Improves Remote Monitoring Timeliness and Heart Failure Alert Metrics.

Journal of cardiovascular translational research·2025
Same author

Sex-specific 99th percentiles derived from the AACC Universal Sample Bank for the Roche Gen 5 cTnT assay: Comorbidities and statistical methods influence derivation of reference limits.

Clinical biochemistry·2017
Same author

Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association.

Circulation·2016
Same author

American Association of Heart Failure Nurses Position Paper on the Certified Heart Failure Nurse - Knowledge (CHFN-K) Certification.

Heart & lung : the journal of critical care·2016
Same author

Diagnosing Sleep Apnea in Patients Hospitalized With Heart Failure: A Role for Advanced Practice Nurses.

AACN advanced critical care·2016
Same author

Sleep and Heart Failure.

Critical care nursing clinics of North America·2015
Same journal

Clinical Immunology for Heart Transplant Nurses: Medication Decision-Making.

AACN advanced critical care·2026
Same journal

How 2 Pediatric Health Care Centers Successfully Implemented Inclusive Hair Care Programs.

AACN advanced critical care·2026
Same journal

Critical Care Consultations for Patients Boarding in the Emergency Department.

AACN advanced critical care·2026
Same journal

Impella 5.5-Assisted Coronary Arterial Bypass Graft in a Patient With Severe Reduced Left Ventricular Function: A Case Report.

AACN advanced critical care·2026
Same journal

Infection in Solid Organ Transplant: Prevention, Risk, and Treatment Strategies.

AACN advanced critical care·2026
Same journal

Alcohol Withdrawal Syndrome Management in the Intensive Care Unit.

AACN advanced critical care·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Cardiorenal dysfunction.

Shawn Merhaut1, Robin J Trupp

  • 1Society of Chest Pain Centers, Columbus, Ohio, USA. smm375@yahoo.com

AACN Advanced Critical Care
|November 4, 2010
PubMed
Summary
This summary is machine-generated.

Cardiorenal syndrome (CRS) involves heart and kidney dysfunction, often coexisting and increasing mortality. This review clarifies CRS pathophysiology, classification, and updated therapeutic strategies.

More Related Videos

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

Related Experiment Videos

Last Updated: Jun 7, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Left ventricular dysfunction and renal dysfunction are prevalent chronic conditions.
  • These conditions frequently coexist, leading to significant morbidity and mortality.
  • The bidirectional interaction between cardiac and renal systems forms the basis of cardiorenal syndrome (CRS).

Purpose of the Study:

  • To present the pathophysiology of cardiorenal syndrome (CRS).
  • To introduce a new classification system for different types of CRS.
  • To discuss therapeutic interventions and novel therapies for CRS.

Main Methods:

  • Review of the pathophysiology of cardiorenal syndrome.
  • Presentation of a new classification for cardiorenal syndrome.
  • Discussion of therapeutic interventions based on the 2010 Acute Dialysis Quality Initiative consensus.

Main Results:

  • Cardiorenal syndrome (CRS) pathophysiology is complex, involving bidirectional organ interactions.
  • A new classification system aids in understanding and diagnosing different CRS types.
  • Current and novel therapeutic strategies are being developed for effective CRS management.

Conclusions:

  • Understanding cardiorenal syndrome (CRS) is crucial for managing patients with coexisting heart and kidney dysfunction.
  • The new classification provides a framework for diagnosis and treatment.
  • Ongoing research and updated recommendations offer hope for improved patient outcomes.